Letter re: A Pre-post Intervention Study Examining the Impact of a Novel Process on Administration Time for Emergent 23.4% Hypertonic Sodium Chloride Boluses
J Pharm Pract. 2024 Dec 20:8971900241310993.
doi: 10.1177/08971900241310993.
Online ahead of print.